top of page

Telehealth Supports Retention in Treatment for Opioid Use Disorder

Starting buprenorphine treatment for opioid use disorder through telehealth was associated with an increased likelihood of staying in treatment longer compared to starting treatment in a non-telehealth setting, according to a new study analyzing Medicaid data from 2019-2020 in Kentucky and Ohio. These findings add to a growing body of evidence demonstrating positive outcomes associated with the use of telemedicine for treatment of opioid use disorder. Cont.

1 view0 comments

Recent Posts

See All

KSBW | Gov. Gavin Newsom has announced California will crack down harder on a drug that’s typically used as an animal tranquilizer and has now hit the streets— xylazine, often called "tranq." [...] Un

DEA received more than 38,000 comments on its proposed telemedicine rules and continues to carefully consider the input received and is working to promulgate a final set of telemedicine regulations by

bottom of page